201 – 250 of 456
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Prostate cancer early detection : Clinical practice guidelines in oncology™
(
- Contribution to journal › Scientific review
-
Mark
Susceptibility Loci Associated with Prostate Cancer Progression and Mortality
(
- Contribution to journal › Article
- 2009
-
Mark
Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands
(
- Contribution to journal › Article
-
Mark
THE P-MARK BIOBANK: A EUROPEAN MULTICENTER BIOREPOSITORY FOR PROSTATE CANCER RESEARCH
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.165-165(
- Contribution to journal › Published meeting abstract
-
Mark
Risk of Dying From Prostate Cancer in Men Randomized to Screening Differences Between Attendees and Nonattendees
(
- Contribution to journal › Article
-
Mark
Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(
- Contribution to journal › Article
-
Mark
Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
(
- Contribution to journal › Article
-
Mark
Increase in percent free prostate-specific antigen in men with chronic kidney disease.
2009) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 24. p.1238-1241(
- Contribution to journal › Article
-
Mark
Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
(
- Contribution to journal › Article
-
Mark
THE CONTINUING ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: 'DO NOT THROW THE BABY OUT WITH THE BATH WATER'
(
- Contribution to journal › Article
-
Mark
Acoustic Whole Blood Plasmapheresis Chip for Prostate Specific Antigen Microarray Diagnostics.
(
- Contribution to journal › Article
-
Mark
Association of Reported Prostate Cancer Risk Alleles With PSA Levels Among Men Without a Diagnosis of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Multiplex approach for identification of PSA variants in clinical samples
(
- Contribution to journal › Published meeting abstract
-
Mark
Prostate cancer : Estimating the benefits of PSA screening
(
- Contribution to journal › Article
-
Mark
Cutpoints in clinical chemistry : Time for fundamental reassessment
(
- Contribution to journal › Article
-
Mark
Acoustic whole blood plasmapheresis chip for PSA microarray diagnostics
2009) 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2009 In Proceedings of Conference, MicroTAS 2009 - The 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences p.1330-1332(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Molecular insights into substrate specificity of prostate specific antigen through structural modeling
(
- Contribution to journal › Article
-
Mark
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy
(
- Contribution to journal › Article
-
Mark
NF-κB regulates androgen receptor expression and prostate cancer growth
(
- Contribution to journal › Article
-
Mark
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer : Concordance with CellSearch assay and association with bone metastases and with survival
(
- Contribution to journal › Article
-
Mark
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Systematic review of Pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer
(
- Contribution to journal › Article
-
Mark
In reply
(
- Contribution to journal › Letter
-
Mark
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
PSA quantification of 80 plasma samples from the clinical routine using antibody microarrays
2009) 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2009 In Proceedings of Conference, MicroTAS 2009 - The 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences p.457-459(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Maldi-target integrated microfluidic PSA assay
2009) 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2009 In Proceedings of Conference, MicroTAS 2009 - The 13th International Conference on Miniaturized Systems for Chemistry and Life Sciences p.1064-1066(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Screening and Prostate-Cancer Mortality in a Randomized European Study
(
- Contribution to journal › Article
- 2008
-
Mark
Beta-microseminoprotein in serum correlates with the levels in seminal plasma of young, healthy males
(
- Contribution to journal › Article
-
Mark
Total prostate specific antigen stability confirmed after long-term storage of serum at -80C - Comment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
ENSAM: Europium Nanoparticles for Signal Enhancement of Antibody Microarrays on Nanoporous Silicon.
(
- Contribution to journal › Article
-
Mark
The role of SPINK1 in ETS rearrangement-negative prostate cancers
(
- Contribution to journal › Article
-
Mark
Long-term prediction of prostate cancer: Prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
(
- Contribution to journal › Scientific review
-
Mark
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study
(
- Contribution to journal › Article
-
Mark
Alteration of prostate specific antigen (PSA) in blood linked to cancer
2008) Swedish Proteomics Society Symposium, 2008(
- Contribution to conference › Abstract
-
Mark
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
(
- Contribution to journal › Scientific review
-
Mark
Systematic review of statistical methods used in molecular marker studies in cancer
(
- Contribution to journal › Article
-
Mark
Five genetic variants associated with prostate cancer [9]
(
- Contribution to journal › Letter
-
Mark
Testing new PSA subforms to enhance the accuracy of predicting cancer risk and disease outcome in prostate cancer
(
- Contribution to journal › Article
-
Mark
Serum Markers for Prostate Cancer : A Rational Approach to the Literature
(
- Contribution to journal › Scientific review
-
Mark
Screening for prostate cancer : an update.
(
- Contribution to journal › Scientific review
- 2007
-
Mark
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically-based screening strategy
(
- Contribution to journal › Article
-
Mark
A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.
(
- Contribution to journal › Article
-
Mark
Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood
(
- Contribution to journal › Article
-
Mark
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
(
- Contribution to journal › Article
-
Mark
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial
(
- Contribution to journal › Article
-
Mark
Circulating biomarkers for prostate cancer
(
- Contribution to journal › Article